» Articles » PMID: 15176485

Gene Expression Profiling in Fetal, Aged, and Alzheimer Hippocampus: a Continuum of Stress-related Signaling

Overview
Journal Neurochem Res
Specialties Chemistry
Neurology
Date 2004 Jun 5
PMID 15176485
Citations 84
Authors
Affiliations
Soon will be listed here.
Abstract

While specific components of normal brain aging and Alzheimer's disease (AD) appear to be genetically determined, it is not well understood whether AD is due to accelerated aging or if AD represents an independent disease entity superimposed upon senescence. Using gene expression profiling, significant alterations in brain-specific transcription patterns have been observed between AD and age-matched controls. In AD, although a general depression in brain genetic output has been reported, there are robust increases in the expression of potentially neuropathological genes. The data in this study show increases in the RNA abundance patterns for a stress-response, proinflammatory, apoptotic, and angiogenic gene family that occur during the transition from fetal to aged, and again during the transformation from aged to AD brain. Significantly up-regulated RNAs include those encoding stress-induced factors (HSP70), transcriptional repressors (DAXX), pentraxins (SAP), proapoptosis factors (FAS and DAXX), and several inflammatory markers (betaAPP, CEX1, NF-IL6, NF-kappaBp100, cyclooxygenase-2, IL-1alpha and IL-1beta precursors and cPLA2). These findings support the hypothesis that there is a continuum of stress-related gene expression as the brain ages and an advancement of inflammatory, apoptotic, and angiogenic gene signaling that correlates with the transition to AD.

Citing Articles

FSH and ApoE4 contribute to Alzheimer's disease-like pathogenesis via C/EBPβ/δ-secretase in female mice.

Xiong J, Kang S, Wang M, Wang Z, Xia Y, Liao J Nat Commun. 2023; 14(1):6577.

PMID: 37852961 PMC: 10584868. DOI: 10.1038/s41467-023-42282-7.


MicroRNA (miRNA) Complexity in Alzheimer's Disease (AD).

Lukiw W Biology (Basel). 2023; 12(6).

PMID: 37372073 PMC: 10295300. DOI: 10.3390/biology12060788.


Assessment of the neuroprotective potential of d-cycloserine and l-serine in aluminum chloride-induced experimental models of Alzheimer's disease: and studies.

Tozlu O, Turkez H, Okkay U, Ceylan O, Bayram C, Hacimuftuoglu A Front Nutr. 2022; 9:981889.

PMID: 36159454 PMC: 9493202. DOI: 10.3389/fnut.2022.981889.


Glyphosate infiltrates the brain and increases pro-inflammatory cytokine TNFα: implications for neurodegenerative disorders.

Winstone J, Pathak K, Winslow W, Piras I, White J, Sharma R J Neuroinflammation. 2022; 19(1):193.

PMID: 35897073 PMC: 9331154. DOI: 10.1186/s12974-022-02544-5.


The Dynamic Role of Microglia and the Endocannabinoid System in Neuroinflammation.

Young A, Denovan-Wright E Front Pharmacol. 2022; 12:806417.

PMID: 35185547 PMC: 8854262. DOI: 10.3389/fphar.2021.806417.


References
1.
Hromas R, Gray P, Chantry D, Godiska R, Krathwohl M, Fife K . Cloning and characterization of exodus, a novel beta-chemokine. Blood. 1997; 89(9):3315-22. View

2.
Salazar A, Pinto X, Mana J . Serum amyloid A and high-density lipoprotein cholesterol: serum markers of inflammation in sarcoidosis and other systemic disorders. Eur J Clin Invest. 2002; 31(12):1070-7. DOI: 10.1046/j.1365-2362.2001.00913.x. View

3.
HEYMAN A, Fillenbaum G, Welsh-Bohmer K, Gearing M, Mirra S, Mohs R . Cerebral infarcts in patients with autopsy-proven Alzheimer's disease: CERAD, part XVIII. Consortium to Establish a Registry for Alzheimer's Disease. Neurology. 1998; 51(1):159-62. DOI: 10.1212/wnl.51.1.159. View

4.
Bazan N, Lukiw W . Cyclooxygenase-2 and presenilin-1 gene expression induced by interleukin-1beta and amyloid beta 42 peptide is potentiated by hypoxia in primary human neural cells. J Biol Chem. 2002; 277(33):30359-67. DOI: 10.1074/jbc.M203201200. View

5.
Yang X, Khosravi-Far R, Chang H, Baltimore D . Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell. 1997; 89(7):1067-76. PMC: 2989411. DOI: 10.1016/s0092-8674(00)80294-9. View